Literature DB >> 19415227

Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling.

Ryan C Riddle1, Richa Khatri, Ernestina Schipani, Thomas L Clemens.   

Abstract

Angiogenesis and osteogenesis are tightly coupled during bone development and regeneration. The vasculature supplies oxygen to developing and regenerating bone and also delivers critical signals to the stroma that stimulate mesenchymal cell specification to promote bone formation. Recent studies suggest that the hypoxia-inducible factors (HIFs) are required for the initiation of the angiogenic-osteogenic cascade. Genetic manipulation of individual components of the HIF/vascular endothelial growth factor (VEGF) pathway in mice has provided clues to how coupling is achieved. In this article, we review the current understanding of the cellular and molecular mechanisms responsible for angiogenic-osteogenic coupling. We also briefly discuss the therapeutic manipulation of HIF and VEGF in skeletal repair. Such discoveries suggest promising approaches for the development of novel therapies to improve bone accretion and repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415227      PMCID: PMC3189695          DOI: 10.1007/s00109-009-0477-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  84 in total

1.  Mouse hypoxia-inducible factor-1alpha is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter.

Authors:  R H Wenger; A Rolfs; P Spielmann; D R Zimmermann; M Gassmann
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

2.  Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Authors:  H Hsu; D L Lacey; C R Dunstan; I Solovyev; A Colombero; E Timms; H L Tan; G Elliott; M J Kelley; I Sarosi; L Wang; X Z Xia; R Elliott; L Chiu; T Black; S Scully; C Capparelli; S Morony; G Shimamoto; M B Bass; W J Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Does adult fracture repair recapitulate embryonic skeletal formation?

Authors:  C Ferguson; E Alpern; T Miclau; J A Helms
Journal:  Mech Dev       Date:  1999-09       Impact factor: 1.882

4.  Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells.

Authors:  D S Wang; K Yamazaki; K Nohtomi; K Shizume; K Ohsumi; M Shibuya; H Demura; K Sato
Journal:  J Bone Miner Res       Date:  1996-04       Impact factor: 6.741

5.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.

Authors:  H P Gerber; T H Vu; A M Ryan; J Kowalski; Z Werb; N Ferrara
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

6.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

Authors:  B Barleon; S Sozzani; D Zhou; H A Weich; A Mantovani; D Marmé
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

7.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

8.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

Review 9.  Angiogenesis in fracture repair.

Authors:  J Glowacki
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

10.  Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption.

Authors:  S Niida; M Kaku; H Amano; H Yoshida; H Kataoka; S Nishikawa; K Tanne; N Maeda; S Nishikawa; H Kodama
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

View more
  57 in total

Review 1.  Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling.

Authors:  Kurt D Hankenson; Mariya T Sweetwyne; Hailu Shitaye; Karen L Posey
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

Review 2.  The Key Role of the Blood Supply to Bone.

Authors:  Massimo Marenzana; Timothy R Arnett
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

Review 3.  The Roles and Mechanisms of Actions of Vitamin C in Bone: New Developments.

Authors:  Patrick Aghajanian; Susan Hall; Montri D Wongworawat; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2015-10-07       Impact factor: 6.741

4.  Recent advances in vascular biology and their clinical relevance.

Authors:  Gregg Semenza
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

Review 5.  Biological perspectives of delayed fracture healing.

Authors:  K D Hankenson; G Zimmerman; R Marcucio
Journal:  Injury       Date:  2014-06       Impact factor: 2.586

6.  Spatiotemporal Analyses of Osteogenesis and Angiogenesis via Intravital Imaging in Cranial Bone Defect Repair.

Authors:  Chunlan Huang; Vincent P Ness; Xiaochuan Yang; Hongli Chen; Jiebo Luo; Edward B Brown; Xinping Zhang
Journal:  J Bone Miner Res       Date:  2015-07       Impact factor: 6.741

7.  Angiogenic-osteogenic coupling: the endothelial perspective.

Authors:  Christa Maes; Thomas L Clemens
Journal:  Bonekey Rep       Date:  2014-10-15

8.  Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects.

Authors:  Masashi Osugi; Wataru Katagiri; Ryoko Yoshimi; Takeharu Inukai; Hideharu Hibi; Minoru Ueda
Journal:  Tissue Eng Part A       Date:  2012-06-12       Impact factor: 3.845

Review 9.  Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies.

Authors:  Betsabel Chicana; Cristine Donham; Alberto J Millan; Jennifer O Manilay
Journal:  Curr Osteoporos Rep       Date:  2019-04       Impact factor: 5.096

10.  Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential.

Authors:  Hao Ding; You-Shui Gao; Yang Wang; Chen Hu; Yuan Sun; Changqing Zhang
Journal:  Stem Cells Dev       Date:  2014-01-24       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.